Original Article
Increased Concentrations of Soluble CD40 Ligand Platelet in Patients With Primary Antiphospholipidic Syndrome
Incremento en las concentraciones de ligando CD40 soluble plaquetario en pacientes con síndrome antifosfolipídico primario
Aida Galicia Lópeza, Lourdes Olguín Ortegaa, Miguel A. Saavedraa, René Méndez Cruzb, Rafael Jimenez Floresb, Maximiliano García de la Peñac,
Corresponding author
a Departamento de Reumatología, Hospital de Especialidades “Dr. Antonio Fraga Mouret”, Centro Médico Nacional “La Raza”, Instituto Mexicano del Seguro Social, Mexico City, Mexico
b Laboratorio de Inmunología, Facultad de Estudios Superiores Iztacala, Universidad Autónoma de México, Mexico City, Mexico
c Coordinación de Planeación de Infraestructura Médica, Instituto Mexicano del Seguro Social, Mexico City, Mexico
Read
6967
Timeswas read the article
2314
Total PDF
4653
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 0 | 4 | 4 |
| 2025 5 | 86 | 59 | 145 |
| 2025 4 | 65 | 25 | 90 |
| 2025 3 | 82 | 31 | 113 |
| 2025 2 | 74 | 27 | 101 |
| 2025 1 | 67 | 51 | 118 |
| 2024 12 | 35 | 29 | 64 |
| 2024 11 | 53 | 71 | 124 |
| 2024 10 | 28 | 31 | 59 |
| 2024 9 | 37 | 17 | 54 |
| 2024 8 | 57 | 26 | 83 |
| 2024 7 | 31 | 28 | 59 |
| 2024 6 | 41 | 27 | 68 |
| 2024 5 | 47 | 35 | 82 |
| 2024 4 | 50 | 18 | 68 |
| 2024 3 | 39 | 24 | 63 |
| 2024 2 | 51 | 25 | 76 |
| 2024 1 | 29 | 15 | 44 |
| 2023 12 | 25 | 26 | 51 |
| 2023 11 | 28 | 30 | 58 |
| 2023 10 | 25 | 28 | 53 |
| 2023 9 | 88 | 30 | 118 |
| 2023 8 | 32 | 12 | 44 |
| 2023 7 | 39 | 28 | 67 |
| 2023 6 | 61 | 20 | 81 |
| 2023 5 | 36 | 22 | 58 |
| 2023 4 | 35 | 5 | 40 |
| 2023 3 | 70 | 25 | 95 |
| 2023 2 | 63 | 30 | 93 |
| 2023 1 | 40 | 21 | 61 |
| 2022 12 | 48 | 28 | 76 |
| 2022 11 | 78 | 24 | 102 |
| 2022 10 | 56 | 40 | 96 |
| 2022 9 | 46 | 26 | 72 |
| 2022 8 | 62 | 39 | 101 |
| 2022 7 | 55 | 47 | 102 |
| 2022 6 | 74 | 38 | 112 |
| 2022 5 | 63 | 45 | 108 |
| 2022 4 | 31 | 45 | 76 |
| 2022 3 | 41 | 60 | 101 |
| 2022 2 | 40 | 38 | 78 |
| 2022 1 | 30 | 39 | 69 |
| 2021 12 | 24 | 30 | 54 |
| 2021 11 | 42 | 53 | 95 |
| 2021 10 | 42 | 44 | 86 |
| 2021 9 | 41 | 42 | 83 |
| 2021 8 | 32 | 49 | 81 |
| 2021 7 | 36 | 32 | 68 |
| 2021 6 | 38 | 34 | 72 |
| 2021 5 | 43 | 32 | 75 |
| 2021 4 | 52 | 67 | 119 |
| 2021 3 | 55 | 24 | 79 |
| 2021 2 | 35 | 26 | 61 |
| 2021 1 | 25 | 20 | 45 |
| 2020 12 | 27 | 6 | 33 |
| 2020 11 | 26 | 18 | 44 |
| 2020 10 | 26 | 6 | 32 |
| 2020 9 | 25 | 21 | 46 |
| 2020 8 | 24 | 8 | 32 |
| 2020 7 | 21 | 12 | 33 |
| 2020 6 | 23 | 16 | 39 |
| 2020 5 | 32 | 15 | 47 |
| 2020 4 | 22 | 13 | 35 |
| 2020 3 | 17 | 5 | 22 |
| 2019 4 | 2 | 0 | 2 |
| 2019 1 | 1 | 0 | 1 |
| 2018 5 | 4 | 0 | 4 |
| 2018 4 | 49 | 6 | 55 |
| 2018 3 | 66 | 5 | 71 |
| 2018 2 | 31 | 3 | 34 |
| 2018 1 | 30 | 10 | 40 |
| 2017 12 | 27 | 4 | 31 |
| 2017 11 | 31 | 7 | 38 |
| 2017 10 | 20 | 4 | 24 |
| 2017 9 | 32 | 2 | 34 |
| 2017 8 | 36 | 11 | 47 |
| 2017 7 | 36 | 14 | 50 |
| 2017 6 | 50 | 10 | 60 |
| 2017 5 | 52 | 8 | 60 |
| 2017 4 | 23 | 6 | 29 |
| 2017 3 | 34 | 7 | 41 |
| 2017 2 | 28 | 7 | 35 |
| 2017 1 | 27 | 4 | 31 |
| 2016 12 | 69 | 16 | 85 |
| 2016 11 | 41 | 0 | 41 |
| 2016 10 | 69 | 8 | 77 |
| 2016 9 | 56 | 12 | 68 |
| 2016 8 | 52 | 9 | 61 |
| 2016 7 | 26 | 3 | 29 |
| 2016 5 | 3 | 15 | 18 |
| 2016 1 | 1 | 0 | 1 |
| 2015 12 | 1 | 0 | 1 |
| 2015 11 | 1 | 0 | 1 |
| 2015 10 | 2 | 13 | 15 |
| 2015 9 | 2 | 0 | 2 |
| 2015 7 | 24 | 6 | 30 |
| 2015 6 | 25 | 9 | 34 |
| 2015 5 | 63 | 15 | 78 |
| 2015 4 | 28 | 8 | 36 |
| 2015 3 | 23 | 5 | 28 |
| 2015 2 | 24 | 2 | 26 |
| 2015 1 | 34 | 3 | 37 |
| 2014 12 | 39 | 8 | 47 |
| 2014 11 | 21 | 12 | 33 |
| 2014 10 | 41 | 8 | 49 |
| 2014 9 | 24 | 12 | 36 |
| 2014 8 | 38 | 11 | 49 |
| 2014 7 | 30 | 11 | 41 |
| 2014 6 | 54 | 14 | 68 |
| 2014 5 | 47 | 15 | 62 |
| 2014 4 | 49 | 8 | 57 |
| 2014 3 | 60 | 15 | 75 |
| 2014 2 | 46 | 12 | 58 |
| 2014 1 | 46 | 11 | 57 |
| 2013 12 | 41 | 8 | 49 |
| 2013 11 | 45 | 8 | 53 |
| 2013 10 | 50 | 11 | 61 |
| 2013 9 | 40 | 12 | 52 |
| 2013 8 | 73 | 26 | 99 |
| 2013 7 | 40 | 18 | 58 |
Show all
